Eko Low Ejection Fraction Tool (ELEFT) vs VX1+
AI Verdict
Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary goal is to non-invasively screen patients for early indicators of heart failure during routine physical examinations. This tool is ideal for clinicians, including family medicine practitioners and cardiologists, seeking to quickly identify low ejection fraction using a digital stethoscope and AI-powered analysis to aid in proactive patient management.
View Eko Low Ejection Fraction Tool (ELEFT) →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and require real-time AI-driven insights during the intervention. This software is specifically designed to assist in the identification of abnormal and spatio-temporal dispersed electrograms (DEs) within the operating room, integrating with existing EP mapping systems to enhance procedural precision.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | VX1+ |
|---|---|---|
| Deployment | Unknown | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) integrates with familiar Eko digital stethoscopes and provides results in approximately 15 seconds during routine physical exams, making it highly accessible and easy to incorporate into existing workflows for a broad range of clinicians. VX1+ is designed for highly specialized cardiac ablation procedures, which are inherently more complex, even with its simple color-coded interface.
Clinical Value
Eko Low Ejection Fraction Tool (ELEFT)ELEFT aids in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams, addressing a widespread and often underdiagnosed condition with significant population-level impact. VX1+ assists electrophysiologists in real-time identification of abnormal electrograms during complex cardiac ablation procedures, aiming to improve the efficacy of a specialized intervention. While both offer significant value, ELEFT's potential for broad, early detection of a prevalent condition gives it an edge in overall clinical impact.
Pricing & Value
TieNeither ELEFT nor VX1+ provides publicly available pricing information, making a direct comparison of their pricing and value proposition impossible. Both are enterprise solutions, suggesting a significant investment, and require direct contact with sales for specific pricing details.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)ELEFT is explicitly stated to be HIPAA compliant and offers a Business Associate Agreement (BAA), which are critical for enterprise adoption and data security in healthcare. While VX1+ is expected to meet these standards for a medical device handling patient data in the U.S., ELEFT's explicit confirmation provides greater assurance for enterprise readiness. Both are FDA-cleared and designed for integration into clinical workflows.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)ELEFT innovates by integrating AI-powered diagnostics into a common, non-invasive tool (the stethoscope) for early heart failure detection during routine physical exams, democratizing access to advanced diagnostics at the point of care. VX1+ is also highly innovative in applying AI to real-time, complex electrophysiology procedures to improve ablation targeting. However, ELEFT's broader applicability to primary care and its integration with a foundational clinical tool represent a more widespread innovation in healthcare delivery.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health provides a dedicated help center for individual customers, options to schedule calls with customer experience, and a support ticket system, indicating structured support channels. For enterprise users of SENSORAu2122 (which includes ELEFT), a separate help center is available. Volta Medical's contact information is available, but specific details on support channels or comprehensive documentation for VX1+ are not as explicitly detailed or easily accessible through web search.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | VX1+ |
|---|---|---|
| Tool Name | Eko Low Ejection Fraction Tool (ELEFT) | VX1+ |
| Primary Function | Aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Company | Eko Health | Volta Medical |
| Target Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
| Key AI Application | AI-powered low ejection fraction detection | Real-time identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures |
| Integration/Compatibility | Integrates with FDA-cleared Eko digital stethoscopes | Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system) |
Videos
Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and VX1+.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Low Ejection Fraction Tool (ELEFT) or VX1+
Backers
Who funded each tool's parent company.